Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2011 Filed Mar 22, 2011 22:26 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 326.777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019255 · doc4.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,512.777 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:27 UTC |
BURKE RICHARD TDirector
|
GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019256 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,586,510 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:27 UTC |
DARRETTA ROBERT JDirector
|
GrantCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019257 · doc4.xml · nonDerivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,631 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:29 UTC |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019259 · doc4.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,960 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:28 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
GrantCommon Stock | 240.782 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019258 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,613,992.782 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:29 UTC |
LAWSON RODGER ADirector
|
GrantCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019260 · doc4.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,269 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:30 UTC |
LEATHERDALE DOUGLAS WDirector
|
GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019261 · doc4.xml · nonDerivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899,455 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:31 UTC |
Mikan George Lawrence IIIEVP UHG & CEO, Optum
|
GrantCommon Stock | 326.777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019262 · doc4.xml · nonDerivative · entry 1 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,170.777 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:32 UTC |
MUNSELL WILLIAM AEVP, UnitedHealth Group
|
GrantCommon Stock | 154.79 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019263 · doc4.xml · nonDerivative · entry 1 MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,157.79 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:32 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
GrantCommon Stock | 34.397 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019264 · doc4.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,695.397 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:33 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019266 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,331 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:33 UTC |
RENFRO LARRY CEVP, UnitedHealth Group
|
GrantCommon Stock | 326.777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019265 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,174.777 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:34 UTC |
Shine Kenneth IrwinDirector
|
GrantCommon Stock | 27 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019267 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,504 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:35 UTC |
Tuckson Reed VaughnEVP & Chief of Medical Affairs
|
GrantCommon Stock | 68.795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019269 · doc4.xml · nonDerivative · entry 1 Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,014.795 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:35 UTC |
Sweere LoriEVP, Human Capital
|
GrantCommon Stock | 68.795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019268 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,456.795 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:36 UTC |
Walsh Christopher JamesEVP and General Counsel
|
GrantCommon Stock | 68.795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019270 · doc4.xml · nonDerivative · entry 1 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,887.795 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:37 UTC |
WELTERS ANTHONYEVP, UnitedHealth Group
|
GrantCommon Stock | 154.79 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019271 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,666.79 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:38 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019273 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,430 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:37 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
GrantCommon Stock | 326.777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019272 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,941.777 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:38 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
GrantCommon Stock | 68.795 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019274 · doc4.xml · nonDerivative · entry 1 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,814.795 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 17, 2011 Filed Nov 14, 2011 22:02 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
GiftCommon Stock | 2,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-055795 · doc4.xml · nonDerivative · entry 5 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,540.604 Read SEC document |
| March 17, 2011 Filed Nov 14, 2011 22:02 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
GiftCommon Stock | 12,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-055795 · doc4.xml · nonDerivative · entry 4 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Indirect · by Insurance Trust Disclosed balance after: 12,229 Read SEC document |
| March 17, 2011 Filed Nov 14, 2011 22:02 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-055795 · doc4.xml · nonDerivative · entry 3 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Indirect · by 2009-M Annuity Trust Disclosed balance after: 0 Read SEC document |
| March 14, 2011 Filed Mar 15, 2011 21:51 UTC |
Walsh Christopher JamesEVP and General Counsel
|
SaleCommon Stock | 3,450 | $43.26 | $149,247.00 |
DisclosureSEC source: 0001209191-11-018133 · doc4.xml · nonDerivative · entry 1 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,819 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2011. Read SEC document |
| March 10, 2011 Filed Mar 11, 2011 21:29 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
SaleCommon Stock | 4,287 | $43.85 | $187,963.52 |
DisclosureSEC source: 0001209191-11-017353 · doc4.xml · nonDerivative · entry 5 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,746 Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:28 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionNon-qualified stock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.63 | $0.00 |
DisclosureSEC source: 0001209191-11-017352 · doc4.xml · derivative · entry 3 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2011-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:28 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionCommon Stock | 10,000 | $14.63 | $146,250.00 |
DisclosureSEC source: 0001209191-11-017352 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,586,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:29 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 9,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001209191-11-017353 · doc4.xml · derivative · entry 7 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,012 Underlying: Common Stock · 9,000 shares Expires 2020-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:29 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 25,000 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0001209191-11-017353 · doc4.xml · derivative · entry 6 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,200 Underlying: Common Stock · 25,000 shares Expires 2018-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:29 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Tax withholdingCommon Stock | 7,669 | $44.49 | $341,193.81 |
DisclosureSEC source: 0001209191-11-017353 · doc4.xml · nonDerivative · entry 4 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,033 Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:29 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Exercise / conversionCommon Stock | 9,000 | $33.00 | $297,000.00 |
DisclosureSEC source: 0001209191-11-017353 · doc4.xml · nonDerivative · entry 3 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:29 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Tax withholdingCommon Stock | 21,604 | $44.49 | $961,161.96 |
DisclosureSEC source: 0001209191-11-017353 · doc4.xml · nonDerivative · entry 2 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,702 Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:29 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Exercise / conversionCommon Stock | 25,000 | $33.94 | $848,500.00 |
DisclosureSEC source: 0001209191-11-017353 · doc4.xml · nonDerivative · entry 1 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2011 Filed Feb 24, 2011 22:30 UTC |
LEATHERDALE DOUGLAS WDirector
|
SaleCommon Stock | 10,000 | $42.97 | $429,706.00 |
DisclosureSEC source: 0001209191-11-012492 · doc4.xml · nonDerivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899,433 F1 · price: This transaction was executed in multiple trades ranging from $42.94 to $42.98 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 23, 2011 Filed Feb 24, 2011 22:32 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
SaleCommon Stock | 1,763 | $43.38 | $76,485.99 |
DisclosureSEC source: 0001209191-11-012497 · doc4.xml · nonDerivative · entry 3 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,306 Read SEC document |
| February 22, 2011 Filed Feb 24, 2011 22:32 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-11-012497 · doc4.xml · derivative · entry 4 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,342 Underlying: Common Stock · 10,000 shares Expires 2019-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 22, 2011 Filed Feb 24, 2011 22:32 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Tax withholdingCommon Stock | 8,237 | $42.96 | $353,861.52 |
DisclosureSEC source: 0001209191-11-012497 · doc4.xml · nonDerivative · entry 2 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,069 Read SEC document |
| February 22, 2011 Filed Feb 24, 2011 22:32 UTC |
Zamoff Mitchell EliotEVP and General Counsel
|
Exercise / conversionCommon Stock | 10,000 | $29.74 | $297,400.00 |
DisclosureSEC source: 0001209191-11-012497 · doc4.xml · nonDerivative · entry 1 Zamoff Mitchell Eliot · CIK 0001475140 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2011 Filed Feb 22, 2011 21:40 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
Tax withholdingCommon Stock | 2,862 | $42.84 | $122,608.08 |
DisclosureSEC source: 0001209191-11-011586 · doc4.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,661 Read SEC document |
| February 18, 2011 Filed Feb 22, 2011 21:41 UTC |
Walsh Christopher JamesEVP and General Counsel
|
SaleCommon Stock | 1,728 | $42.62 | $73,639.24 |
DisclosureSEC source: 0001209191-11-011587 · doc4.xml · nonDerivative · entry 3 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,269 F1 · price: This transaction was executed in multiple trades ranging from $42.56 to $42.66 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 17, 2011 Filed Feb 22, 2011 21:41 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-11-011587 · doc4.xml · derivative · entry 4 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,842 Underlying: Common Stock · 10,000 shares Expires 2019-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 17, 2011 Filed Feb 22, 2011 21:41 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Tax withholdingCommon Stock | 8,272 | $42.59 | $352,304.48 |
DisclosureSEC source: 0001209191-11-011587 · doc4.xml · nonDerivative · entry 2 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,997 Read SEC document |
| February 17, 2011 Filed Feb 22, 2011 21:41 UTC |
Walsh Christopher JamesEVP and General Counsel
|
Exercise / conversionCommon Stock | 10,000 | $29.74 | $297,400.00 |
DisclosureSEC source: 0001209191-11-011587 · doc4.xml · nonDerivative · entry 1 Walsh Christopher James · CIK 0001475141 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2011 Filed Feb 15, 2011 00:33 UTC |
Sweere LoriEVP, Human Capital
|
SaleCommon Stock | 5,990 | $42.52 | $254,711.57 |
DisclosureSEC source: 0001209191-11-009397 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,388 F1 · price: This transaction was executed in multiple trades ranging from $42.43 to $42.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:27 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
GrantCommon Stock | 83,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008860 · doc4.xml · nonDerivative · entry 2 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,613,752 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 83,195. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:27 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
Tax withholdingCommon Stock | 3,324 | $42.07 | $139,840.68 |
DisclosureSEC source: 0001209191-11-008860 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,530,557 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:26 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 59,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008859 · doc4.xml · nonDerivative · entry 3 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,186 F2 · shares: The restricted stock units will vest 100% on the fourth anniversary of the grant date. F3 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:26 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 53,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008859 · doc4.xml · nonDerivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,761 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:26 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 2,478 | $42.07 | $104,249.46 |
DisclosureSEC source: 0001209191-11-008859 · doc4.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,278 Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:27 UTC |
Mikan George Lawrence IIIEVP UHG & CEO, Health Services
|
GrantCommon Stock | 59,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008861 · doc4.xml · nonDerivative · entry 3 Mikan George Lawrence III · CIK 0001381037 · EVP UHG & CEO, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,844 F2 · shares: The restricted stock units will vest 100% on the fourth anniversary of the grant date. F3 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.